Redefining What Aging Can Look Like
The image of aging that most people carry — progressive decline in strength, cognition, vitality, and independence — is not inevitable. It is, in large part, a picture of unmanaged hormonal decline combined with inadequate lifestyle practices. The growing number of individuals in their 60s and beyond who are outperforming much younger people in physical and cognitive tests — and who maintain genuine vitality, sharpness, and engagement in life — are demonstrating a different possibility. Proactive hormone health management is a core component of this alternative aging trajectory.
The Hormonal Landscape in Your 60s and Beyond
By the 60s, the hormonal changes that began in the 30s have become profound. In men, testosterone may be 50–60% below youthful peak levels. GH and IGF-1 are typically at 20–30% of peak values. DHEA may be less than 25% of its 25-year peak. Thyroid hormone metabolism is often less efficient. Insulin resistance has typically worsened. In women who have not been on hormone therapy, estrogen and progesterone have been near-zero for years or decades, with the bone density, cardiovascular, and cognitive consequences that implies. Testosterone in women continues its decline through the 60s.
Is It Too Late to Start Hormone Therapy?
This question arises frequently in clinical practice, and the answer requires nuance. For women who are more than 10 years post-menopause and over 60, the cardiovascular risk-benefit calculation for systemic estrogen therapy is different than for recently menopausal women — and requires more individualized assessment. Low-dose transdermal estrogen may still be appropriate for symptom management and bone protection in older women with high fracture risk, after careful risk-benefit analysis. Local vaginal estrogen is safe and beneficial for genitourinary symptoms at essentially any age and in most women, including those who have had breast cancer (in consultation with their oncologist).
For men over 60 with confirmed hypogonadism and symptoms, the evidence supports TRT as safe and effective — the TRAVERSE trial’s cardiovascular safety findings applied to a population with a mean age in the 60s. The decision should be individualized based on symptom burden, lab findings, health status, and patient preferences. Starting TRT at 65 with confirmed hypogonadism is not “too late” — the benefits for quality of life, body composition, bone density, and cognitive function are meaningful at any age.
The Longevity Practices That Amplify Hormone Therapy After 60
Hormone therapy after 60 produces its greatest benefits when layered upon strong lifestyle foundations. Resistance training becomes even more critical in the 60s — sarcopenia (age-related muscle loss) accelerates, and maintaining muscle mass is one of the strongest predictors of longevity and functional independence. High protein intake (1.6–2.0g/kg body weight) supports muscle protein synthesis in the face of anabolic resistance. Zone 2 cardio (sustainable aerobic exercise at conversational intensity) supports mitochondrial health, cardiovascular function, and insulin sensitivity. Cognitive engagement — learning new skills, social connection, creative pursuits — supports neuroplasticity alongside any neurological benefits of hormonal optimization.
The goal for hormone health after 60 is not to recapture 30-year-old physiology — it’s to optimize function within the context of where you are now, slow the rate of age-related decline, and maintain the vitality, independence, and engagement with life that defines truly successful aging. With proactive hormonal management, this goal is achievable for more people than the current cultural narrative of aging would suggest.